In Brief
Oct4, Sox2, and Klf4 work collaboratively with the help of other transcription factors to change the enhancer landscape during reprogramming.
INTRODUCTION
Differentiated cells can be reprogrammed to pluripotency by overexpression of the four transcription factors (TFs) Oct4, Sox2, Klf4, and cMyc (OSKM) (Takahashi and Yamanaka, 2006) . Successful reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) leads to the faithful shutdown of the somatic program and activation of the target program. Conversely, in TF-induced conversions of one somatic cell type to another, incomplete extinction of the starting cell program represents a major barrier (Cahan et al., 2014) . Hence, understanding the mechanisms by which OSKM inactivate the starting cell program and induce the pluripotency network will provide insights into the principles by which cell identity can be effectively manipulated.
The interaction of OSKM with chromatin has been primarily studied in ESCs, where O, S, and K preferentially bind enhancers and M primarily associates with promoters (Chen et al., 2008; Kim et al., 2008) . In ESCs, enhancers are often occupied by additional pluripotency TFs including Nanog and Esrrb (Chen et al., 2008; Kim et al., 2008; Whyte et al., 2013) , suggesting that complex regulatory interactions perpetuate the pluripotent state. Among the pluripotency TFs, O, S, and Nanog are thought to form a pivotal circuitry as they co-occupy enhancers with a higher frequency than other TFs (Chen et al., 2008) , raising the questions of why K is an effective reprogramming factor when combined with O and S and how these factors interact during reprogramming. Moreover, it is unclear how and when pluripotency enhancer selection happens during reprogramming given that most pluripotency TFs are only available late in the process (Polo et al., 2012; Samavarchi-Tehrani et al., 2010) . Since enhancers play a central role in driving cell-type-specific gene expression (Heinz et al., 2015) , defining how the reprogramming factors control the reorganization of the enhancer landscape is critical for the mechanistic understanding of reprogramming.
A few studies reported that the target sites of the reprogramming factors change during reprogramming (Chen et al., 2016; Sridharan et al., 2009 ). In addition, it has been shown that O, S, and K each can act as pioneer factor since they can engage nucleosome-occluded sites in human fibroblasts and nucleosomal templates in vitro (Soufi et al., 2012 (Soufi et al., , 2015 . Whether these properties are relevant for their binding to pluripotency enhancers during the reprogramming process, however, remains elusive. Moreover, the pioneer factor model does not provide a mechanistic explanation for the silencing of the somatic program, and, therefore, it has remained unclear how the reprogramming factors would induce this process.
In our study, we delineated the interaction of the reprogramming factors with somatic and pluripotency enhancers. We uncovered that OSK mediate both somatic enhancer silencing and pluripotency enhancer selection through collaborative interactions among themselves and with stage-specific TFs.
RESULTS

Comprehensive Mapping of TFs, Chromatin Features, and Expression at Defined Reprogramming Stages
To characterize the role of OSKM in reprogramming, we carried out chromatin immunoprecipitation for each reprogramming factor coupled to high-throughput sequencing (chromatin immunoprecipitation sequencing [ChIP-seq] ) at four distinct stages of mouse embryonic fibroblast (MEF) reprogramming ( Figure 1A ). These stages included (1) MEFs carrying a tetracycline-inducible polycistronic OSKM expression cassette to capture the starting state; (2) the same MEFs induced for OSKM expression with doxycycline (dox) for 48 hr; (3) two independently generated pre-iPSC lines (pre-i #1 and pre-i #2 ); and (4) the pluripotent state represented by mouse ESCs for the end state ( Figures S1A-S1C ). The 48 hr time point represents an early reprogramming stage and was chosen to examine the initial interaction of OSKM with MEF chromatin. Importantly, within the first 48 hr, fibroblasts respond to OSKM activation in a homogeneous manner and with limited expression changes (Buganim et al., 2012; Koche et al., 2011; Polo et al., 2012) . Since reprogramming cultures are heterogeneous at later time points (Pasque et al., 2014; Polo et al., 2012) , we turned to pre-iPSC lines with closely related transcriptional, epigenetic, and OSKM binding profiles (Figures S1D, S1E, S2E, and S2F) that were isolated clonally from reprogramming cultures infected with OSKM-encoding retroviruses (Sridharan et al., 2009) for a proxy of a late intermediate stage. Since M and K are expressed endogenously in starting MEFs (Figures S1A-S1C), we mapped both in all four reprogramming stages, whereas O and S were profiled at 48 hr, in pre-iPSCs and ESCs.
Additionally, we determined the targets of endogenously expressed TFs (Cebpa, Cebpb, Fra1, Runx1, Esrrb, and Nanog) and chromatin regulators (p300, Hdac1, and Brg1) in relevant reprogramming stages to determine their interplay with OSKM, mapped histone H3 to assess nucleosome occupancy, and measured chromatin accessibility by an assay for transposaseaccessible chromatin using ATAC sequencing (ATAC-seq) and gene expression by RNA sequencing (RNA-seq) ( Figure 1A ) (Tables S1 and S2 ). We also generated maps for nine histone modifications and the histone variant H3.3 for each reprogramming stage. The histone modifications included H3K4me3 and H3K9ac primarily associated with promoters; H3K4me1, H3K4me2, and H3K27ac characteristic of active promoters and enhancers; H3K79me2 and H3K36me3 associated with transcription, and the repressive marks H3K9me3 and H3K27me3 ( Figure 1A ) (Ernst et al., 2011) . A snapshot of the various datasets is shown in Figure 1B . Data reproducibility was confirmed by correlating replicate experiments, experimental and imputed data (Ernst and Kellis, 2015) , and through comparisons with published datasets (Table S3) , leading to the merging of replicate datasets for downstream analyses. Additionally, for TFs, their known motifs were identified at occupied sites ( Figure S1F ), validating our datasets.
Identification of cis-Regulatory Elements at Each Reprogramming Stage
To enable a characterization of the chromatin environment at sites engaged by OSKM, we summarized the combinatorial and spatial patterns of histone modifications and H3.3 for each reprogramming stage by building a chromatin state model with 18 states using ChromHMM and assigned candidate functional annotations to each state based on marks present ( Figure 1C ) (Ernst and Kellis, 2012) . The 18 states defined active and poised promoters, inter-and intragenic enhancers of varying activity levels, various transcribed regions, repressed regions, and genomic regions with minimal or no signal of any histone mark (Figures 1C and 1D) . These chromatin state annotations were supported by associations with genomic landmarks such as CpG islands and transcriptional start sites (TSSs) of genes, chromatin accessibility and expression of nearby genes ( Figures 1D, S1G , and S1H), and captured epigenetic states expected to occur at somatic and pluripotency loci during reprogramming (Figures 1B and S1I) .
OSKM Predominantly Occupy Active and Poised Promoters and Enhancers at Each Reprogramming Stage
To understand OSKM action, we first investigated the characteristics of OSKM binding sites at each reprogramming stage. Regardless of reprogramming stage, O, S, and K predominantly bound in distal regions >2 kb away from the TSS, whereas M binding occurred more often in close proximity to the TSS (Figures 2A and S2A) . Intersection of binding sites with chromatin states revealed that at each reprogramming stage, all four reprogramming factors bound both active and poised promoters and that the distal binding sites of OSK were predominantly located within active enhancers (Figures 2B and S2B) . These binding preferences also applied when considering co-binding between the reprogramming factors, such that M in combinations with O, S, or K displayed strong promoter bias, whereas combinations of O, S, or K binding without M preferentially targeted active enhancers ( Figure S2C ). Sites occupied by O, S, K, or M displayed pronounced nucleosome depletion and chromatin accessibility at the respective stage ( Figures 2C and S2D) . Together, these results demonstrated that OSKM prefer to bind active and poised promoters and enhancers regardless of reprogramming stage. (A) Summary of reprogramming stages and data sets produced. (B) Snapshot of indicated genomics data at a candidate genomic locus. N/A, no data produced. The color code represents the stage-specific chromatin states defined in (C) . Red boxes mark the somatic gene Tgfb3 and the pluripotency gene Esrrb. (C) Rows represent chromatin states and their representative mnemonics, color coded and grouped based on their putative annotation. Cells show the frequency of each histone mark, H3.3, and input signal for each state (ChromHMM emission probabilities). (D) Columns give the percentage of genome occupancy, median length in kilobases (kb), and fold enrichment of indicated features (TES, transcription end sites; TSS, transcription start sites; conservation [phastCons elements]; ERVK, endogenous retrovirus K elements; and ATAC-seq, transposase hypersensitivity) for each chromatin state described in (C) for MEFs and ESCs. Color code per column is from highest to lowest value. See also Figure S1 and Tables S1 and S2. OSKM Redistribution and Binding Partner Switch during Reprogramming A comparison of binding sites between 48 hr, pre-iPSCs, and ESCs revealed that the genomic locations of each reprogramming factor differed dramatically between stages and that the majority of sites were stage-specific (coined ''100,'' ''010,'' and ''001,'' where 1 represents presence and 0 absence of binding, and the digits from left to right binding at 48 hr, pre-i #1 , and ESCs) ( Figures 2D, S2E , and S2F). For instance, 48% of all Oct4 binding events occurred exclusively at 48 hr (100 sites) and 16% were specific for the pluripotent stage (001 sites). 48-hr-specific Oct4 binding events (100 sites) occurred close to genes with fibroblast functions based on gene ontology (GO) analysis, whereas pluripotency-specific sites (001 sites) were linked to genes that control stem cell function and early developmental decisions ( Figure S2G ; Table S4 ), suggesting that stagespecific binding events are associated with stage-specific gene functions. Together, these data revealed the predominant interaction of OSKM with somatic sites early in reprogramming and the redistribution to pluripotency-associated sites at later stages.
The remaining binding events were transient (110 and 011), absent in pre-iPSCs (101), or constitutive (111) (Figures 2D and S2E) . Constitutively bound Oct4 sites, for instance, represented 8% of all 48-hr-bound sites and occurred in the vicinity of genes implicated in blastocyst formation, chromosome organization, and inhibition of MAPK signaling, which is closely tied to the maintenance of pluripotency (Ying et al., 2008) (Figure S2G ; Table S4 ). Thus, the majority of sites associated with the pluripotent state become engaged by the reprogramming factors only late in the process, but certain sites are targeted within the first 48 hr. Motif analysis revealed lower densities of OSKM DNA binding sequences at 100 sites compared to 001 and 111 sites ( Figure S2H ), suggesting that temporal binding events differ in their regulation.
In addition, we found that M binding differed strongly from that of O, S, and K throughout reprogramming and, more surprisingly, that K sites coincided more with those of O and S at 48 hr but diverged from these in pre-iPSCs and the pluripotent state (Figures 2E, S2I, and S2J) . Consequently, we observed significantly more co-binding of OSK and OK at 48 hr than in ESCs and, conversely, an increase in OS co-occupancy in ESCs relative to 48 hr ( Figure 2F ). Thus, co-binding preferences change from OSK/OK to OS during reprogramming, consistent with O and S composing the core pluripotency network in ESCs alongside Nanog instead of K (Chen et al., 2008) .
OSK Co-occupancy at 48 hr Depends on Their Co-expression By comparing K binding between MEFs and 48 hr, we found that many binding sites were gained, whereas others were lost at 48 hr, and only a subset maintained ( Figures 2G and S3A ). Upon overexpression of only Klf4 in MEFs for 48 hr, either retrovirally (K pMX ) or inducibly (K tetO ), without the other reprogramming factors, K predominantly engaged sites that were targeted by it in MEFs and not those newly accessible in the context of OSKM co-expression ( Figure 2G ), despite its higher expression level ( Figure S3B ). We conclude that O and S availability, and not the expression level of K per se, is responsible for the differential binding at 48 hr compared to MEFs. Moreover, whereas sites targeted by endogenous K in MEFs or upon individual overexpression of K carried only the K motif ( Figures 2G, 2H , ''K pMXonly'' and ''shared'' sites, and S3A), new locations bound by K at 48 hr of OSKM reprogramming were co-occupied by O and S and enriched for the motifs of all three factors ( Figures 2G, 2H , K OSKM -only sites, and S3A), revealing an unexpected dependence of K occupancy on O and S early in reprogramming. Conversely, the targeting of O and S, respectively, at 48 hr also strongly depended on the presence of the other reprogramming factors ( Figure 2G ). Specifically, when individually expressed, O and S bound many sites in open MEF chromatin that carried the motif of the respective reprogramming factor ( Figures S3B-S3E ), which did not overlap substantially between the factors ( Figure 2I ). Yet, when co-expressed in the context of OSKM for 48 hr, O and S co-occupied many new sites that also bound K and carried the motifs of all three factors (Figures 2G, 2I, . M was largely dispensable for the redistribution of K and OSK co-binding at 48 hr as co-expression of OSK, without M, led to engagement of largely the same sites at 48 hr as in OSKM-induced reprogramming ( Figure S3F ). We conclude that cooperative binding of O, S, and K is critical for the targeting of a vast number of genomic sites early in reprogramming and additionally restricts access to locations that carry the motif of only one reprogramming factor. S2 and S3 and Tables S2 and S4 .
Enhancers Are Sites of Most Dramatic Chromatin Changes in Reprogramming
To examine the association between temporal OSKM binding events and chromatin changes during reprogramming, we derived an additional chromatin state model that took into consideration the combination of histone marks and H3.3 at any given genomic location within each reprogramming stage as well as the changes of these histone marks/H3.3 between the stages ( Figure 3A ) and defined 35 chromatin states that will be referred to as chromatin trajectories (tr.) hereafter. Based on the histone mark/H3.3 composition of each trajectory, we annotated genomic regions as candidate promoters (tr. 1-4), enhancers (tr. 5-18), units of transcription (tr. 19-27), repressed (tr. 28-32) , transcribed repeats (tr. 33), and devoid of histone marks (tr. 34 and 35). These annotations were consistent with enrichments for genomic landmarks and expression of neighboring genes ( Figures S4A and S4B ). Differences in temporal histone marks/H3.3 composition between the reprogramming stages defined the stage-specific or constitutive chromatin character of each trajectory. We observed that the promoter states (tr. 1-4) did not carry a strong stage-specific identity ( Figures 3A and S4B ) consistent with promoter states being more conserved across cell types (Heintzman et al., 2009) . Around 16% of the genome represented (A) within ±20 kb of the TSS of MEF-and ESC-specific genes compared to ±20 kb of the TSS of all active genes. Values above the dashed line indicate higher enrichment in MEF-and ESC-specific genes, respectively. (C) Fold enrichment of temporal O, S, K, and M binding events defined in Figure 2D for each trajectory in (A) , colored per column from highest to lowest. See also Figure S4 . enhancers, and, in contrast to promoters, the enhancer trajectories strongly differed in their histone mark composition between reprogramming stages and therefore likely in their activity and regulation (Figure 3A, .
Based on the presence of the active enhancer mark H3K27ac in MEFs and its absence in ESCs, we defined MEF enhancers (MEs) ( Figures 3A, S4A , and S4B). MEs were either inter-or intragenic (tr. 5, 6, 9, 10 and 7, 8, respectively) and typically located in the vicinity of genes with fibroblast-specific functions that tended to be expressed specifically early in reprogramming (Figures 3B , S4B, and S4C). Pluripotency enhancers (PEs) were defined based on the presence of H3K27ac in ESCs and near absence in . PEs of tr. 13 and 17 were intergenic, neighboring genes highly expressed in ESCs and implicated in stem cell maintenance, blastocyst formation, and developmental programs based on GO analysis ( Figures 3A, 3B , and S4A-S4C). PEs associated with tr. 14, 15, 16, and 18 were predominantly intragenic or poised (carrying H3K27me3) and close to or within genes that tended to be either constitutively expressed or repressed during reprogramming (Figures 3A and 4B) and implicated in chromatin regulation and cell-fate specification.
One group of intergenic enhancers was marked by H3K4me1/2 at all four stages but displayed activity, defined by H3K27ac presence, in a transient manner at 48 hr and in preiPSCs (tr. 11, transient enhancers) ( Figure 3A ). These enhancers were linked to transiently expressed genes involved in various signaling pathways, most notably those acting in the bone morphogenetic protein (BMP) pathway ( Figures S4B and S4C ). Since BMPs have a positive role early in reprogramming (Samavarchi-Tehrani et al., 2010) , activation of these enhancers may be critical for reprogramming progression. Other enhancers were active exclusively in pre-iPSCs (tr. 12) ( Figure 3A) , and their neighboring genes were enriched for neuronal ontologies (Figure S4C) , consistent with the observation that neuronal genes can be ectopically induced during reprogramming (Ho et al., 2013) . In summary, we identified enhancers as the most dynamic part of the epigenome during reprogramming and defined groups of enhancers that are selectively used at different reprogramming stages.
Changes in OSK Binding Mirror Enhancer
Re-organization To investigate how the redistribution of OSKM relates to the chromatin rearrangement during reprogramming, we intersected the genomic coordinates of temporal OSKM binding events (Figure 2D ) with the chromatin trajectories ( Figure 3A ) and made several key observations ( Figures 3C and S4D ): first, we confirmed that OSK binding predominantly occurred in promoters and enhancers, whereas M preferred promoters throughout reprogramming. Second, the majority of O, S, and K binding events at 48 hr (100, 110 sites) occurred in promoters, MEs, and transient enhancers, indicating that early in reprogramming, O, S, and K predominantly target sites with open chromatin character in starting MEFs, unlike what has been reported for human cell reprogramming (Soufi et al., 2012) . Third, O, S, and K binding at enhancers was typically observed when they were active (based on H3K27ac). For instance, pluripotency-specific O, S, K binding events (001 sites) were enriched specifically within PEs (tr. 13-18). Conversely, 48-hr-specific binding events (100 sites) enriched most in active MEs (tr. 5/6) and transient enhancers (tr. 11). These observations identified a dramatic shift of O, S, and K binding from MEs to PEs during reprogramming that accompanies their inactivation and selection/activation, respectively, and suggested that the reprogramming factors may directly control these two opposing processes. Fourth, we noted that a specific subset of PEs was targeted by O, S, and K early in reprogramming. Among all enhancers, constitutive binding by O, S, and K (111 sites) was most enriched in tr. 13 PEs, and occurred proximal to genes involved in stem cell maintenance, blastocyst formation (Nanog, Lif, Esrrb, Stat3, Nodal, etc.) and negative regulation of MAP kinase signaling ( Figure S4E ), supporting the conclusion that PE selection starts early in reprogramming and is finished in a stepwise manner throughout the process.
Since promoters displayed relatively little stage-specificity with respect to chromatin state and temporal reprogramming factor binding events, whereas enhancers were often stage specific for both ( Figure 3C ), we focused the rest of our study on the targeting and action of OSK at MEs and PEs to understand the regulation of ME silencing and PE selection as well as the regulation of distinct temporal binding patterns of OSK at enhancers. Figure S5 .
MEs Are Suppressed Genome-wide Early in Reprogramming Since it has remained unexplored how MEs become silenced during reprogramming and how the reprogramming factors contribute to this process, we examined active intergenic MEs captured by tr. 5/6 in more detail, approximately half of which were bound by O, S, or K at 48 hr. Considering tr. 5/6 MEs engaged by O, S, or K, we found extensive co-occupancy of these TFs at 48 hr, which was accompanied by an increased ATAC-seq signal ( Figures 4A, 4B , S5A, and S5B). Later in reprogramming, in pre-iPSCs and ESCs, these MEs were depleted of active enhancer marks, OSK binding, and presented diminished chromatin accessibility defined by ATAC-seq ( Figures  4A, 4B , S5A, and S5B), consistent with a predominant 100 OSK binding pattern at these enhancers.
Surprisingly, OSK-bound MEs displayed a lower level of the active enhancer mark H3K27ac at 48 hr compared to MEFs, which was corroborated by decreased binding of the H3K27 acetyltransferase p300 ( Figures 4A, 4B , and S5B), indicating that somatic enhancer inactivation is initiated quite extensively very early in reprogramming. The enhancer marks H3K4me1/2 displayed smaller or no changes at 48 hr ( Figures 4A, S5A , and S5B). The observation that the H3K27ac level was maintained or increased at other genomic locations (tr. 4, 9, and 11) at 48 hr ( Figures S5C-S5E ) argued against a global reduction of p300 activity and H3K27ac. The histone deacetylase Hdac1 was also present at OSK-targeted MEs and, unlike p300, its binding increased at 48 hr ( Figure 4B ), which was also seen in independent replicates, and, as for p300, occurred without alteration in its expression level ( Figure S5F ). We conclude that the change in balance of both p300 and Hdac1 observed at OSKbound MEs at 48 hr likely accounts for the reduction in H3K27ac at these enhancers in the earliest phase of reprogramming. The completion of silencing of these enhancers occurred later indicating that ME inactivation is a stepwise process.
Unexpectedly, we observed that MEs of tr. 5/6 that were not engaged by OSK at 48 hr also had strongly reduced H3K27ac and p300 levels at 48 hr ( Figures 4C, S5A , and S5B). These findings suggested that the disruption of the most active MEs takes place genome-wide early in reprogramming and extends beyond direct OSK targets. Interestingly, the increase in Hdac1 was specific to OSK-bound MEs and not observed at MEs that were not targeted by OSK ( Figures 4B and 4C ), potentially as a consequence of a direct action of O, S, or K.
Loss of Somatic TFs from OSK-Bound and Unbound MEs at 48 hr To investigate how ME activity could be globally affected, we performed de novo motif scanning in OSK-bound and unbound tr. 5 MEs and identified DNA motifs of the Fra1 (AP-1 family), Tead, Runx, and Cebp families of TFs in both sets ( Figure 4D) . O, S, and K motifs were enriched specifically in the bound ME set ( Figure 4D ). We then performed ChIP-seq for the corresponding TFs Fra1, Cebpa, Cebpb, and Runx1, all highly expressed in MEFs ( Figure S6J ) and found that these TFs indeed occupied both OSK-bound and -unbound MEs in MEFs ( Figures 4E-4G To test the functional significance of somatic TF loss, we performed siRNA-mediated knockdown of Runx1 ( Figure 4H ) and Cebpa/b ( Figure S5G ) during reprogramming. Both treatments increased the number of Nanog-positive colonies indicating that the depletion of ME-bound somatic TFs represents a mechanism for improving reprogramming efficiency, likely by augmenting ME inactivation.
Reprogramming Factors Can Individually Induce ME Silencing To determine whether OSK co-expression is required for global ME silencing, we analyzed O and K binding and H3K27ac levels at MEs in MEFs expressing only Oct4 or Klf4 for 48 hr. Only 23% and 31% of tr Somatic TF Redistribution at 48 hr Is Guided by OSK A comparison of peak locations for Cebpa, Cebpb, Runx1, and Fra1 revealed the loss-and gain-of-binding events between MEFs and 48 hr as well as sites that were maintained ( Figures  5A , 5B, S6A, and S6B). Gain and loss of binding occurred predominantly at sites occupied by only one of the somatic TFs ( Figure 5C , clusters I-III and IV-VII), whereas binding sites maintained at 48 hr were more often co-occupied by the somatic TFs ( Figure 5C , cluster VIII). Binding events lost or maintained at 48 hr were located predominantly in MEs (tr. 5-10), promoters (tr. 1-4), as well as transient enhancers (tr. 11) ( Figure 5D , MEF-only and shared sites). Conversely, new binding sites of the somatic TFs at 48 hr were primarily enriched within promoters (tr. 1-4), transient enhancers (tr. 11), and tr. 13 PEs (Figure 5D , 48-hr-only sites). Together, these data revealed an unexpected redistribution of somatic TFs away from sites that include MEs toward new sites that include PEs. 48-hr-specific sites of Cepba, Cebpb, and Fra1, respectively, were extensively co-occupied by O, S, or K at 48 hr (>80%) and had a high density of OSK motifs, whereas MEF-specific sites displayed lower reprogramming factor occupancy (<42%) and lacked OSK motifs (Figures 5A, 5C, 5E, and S6B). Thus, somatic TFs relocate from MEs toward new sites that become available by binding of the reprogramming factors early in reprogramming, suggesting that OSK directly guide this process, which, in turn, leads to the global destabilization of MEs. In support of an inter-dependency of somatic TFs and OSK, we found that somatic TF binding sites maintained at 48 hr were also targets of OSK early in reprogramming ( Figures 5A, 5C , S6A, and S6B) and that Cebpb co-occupied many sites with OSK in pre-iPSCs ( Figure S6C ).
We also noted that somatic TF binding sites maintained at 48 hr (shared sites) exhibited higher normalized tag counts and motif density of the respective TF than either MEF-or 48-hr-specific peaks (Figures 5F, 5G, S6D, and S6E). These results suggested that binding events maintained early in reprogramming display higher affinity for the somatic TF compared to those lost or gained and that OSK induce the relocation of somatic TFs from one set of lower affinity binding sites to another.
Runx1 also relocated early in reprogramming but the new sites at 48 hr occurred often in transcribed units and did not overlap as extensively with OSK binding as Fra1 and Cebpa/b (Figures 5C, 5D, and S6A), suggesting that a different mechanism controls the redistribution of this TF. In addition, we noticed that more sites were lost and fewer sites gained at 48 hr for Fra1 compared to Cebpa/b or Runx1 (Figures 5A, 5C, and S6B, also seen in independent replicates), which raised the question of whether the level of Fra1 was altered. Indeed, RNA-seq revealed limited transcriptional changes early in reprogramming (Figures S6F and S6G) (Koche et al., 2011) with Cebpa, Cepbb, and Runx1 transcript levels remaining largely unchanged, whereas Fra1 transcript levels decreased substantially (2.7-fold) (Figures S6J and S6K; Table S2 ). Hence, repression of Fra1 appears to be an additional mechanism that contributes to the loss of somatic TFs from MEs. Loss of Fra1 binding at its own locus at 48 hr ( Figure S6L ) could enhance the downregulation of this TF via its known auto-regulation (Verde et al., 2007) . Of note, genes upregulated early in reprogramming were enriched for 48-hr-specific somatic TF binding and downregulated genes for MEF-specific somatic TF peaks (Figures S6H and S6I) , suggesting that the redistribution of somatic TFs also contributes to the few expression changes detected early in reprogramming.
Fra1 Repression Is Critical for Somatic Program Silencing and Reprogramming
To test whether Fra1 repression is critical for ME silencing, we ectopically expressed Fra1 or a Flag-tagged version together with OSKM, which dramatically lowered the efficiency of reprogramming ( Figures 5H and S6M ). In comparison, Runx1 overexpression had a more limited inhibitory effect on iPSC formation (Figures 5H and S6M) , again hinting at differential control of reprogramming by Runx1. Ectopic expression of Flag-tagged Fra1 for 48 hr abrogated the loss of Fra1 from MEs that occurred early in OSKM-mediated reprogramming (Figures 5I, clusters III and IV, and S6L). Upon 48 hr overexpression together with OSKM, Fra1 also engaged new sites in promoters, PEs, and transient enhancers that were co-occupied by O and K ( Figure 5I , cluster I, S was not tested here) and induced the targeting of these reprogramming factors to new sites ( Figure 5I , clusters II and V) emphasizing the co-dependency of somatic TF and reprogramming factor binding events. Fra1 overexpression also reversed expression changes observed under standard reprogramming conditions at 48 hr and prevented the upregulation of the epithelial signature gene E-cadherin (Figures 5J and 5K) . These data suggested that Fra1 loss from MEs is critical for their silencing and iPSC production. Overexpression of cJun, the binding partner of Fra1, was also detrimental for reprogramming (Figures 5H and S6M) (Liu et al., 2015) and produced similar expression changes as Fra1 overexpression (Figures 5J and 5K) , suggesting that cJun may block reprogramming in synergy with Fra1.
Stepwise PE Selection Is Not Explained by Starting Chromatin State Besides ME silencing, the selection of PEs is critical for reprogramming. The temporal differences in PE engagement, with a large number of PEs targeted by OSK only late in reprogramming and others first engaged at 48 hr or in pre-iPSCs (Figure 3C) , prompted us to ask what distinguishes temporally different reprogramming factor binding at PEs. We focused this analysis on 111 and 001 O binding events in intergenic PEs of tr. 13 and 17 because of their association with genes involved in stem cell-related functions and high expression in ESCs (Figures S4B , S4C, and S4E). See also Figure S6 and Table S2 .
We first analyzed enhancer-associated histone marks at 111 and 001 O binding events in tr. 13 PEs and 001 O sites in tr. 17 PEs ( Figure 6A ). All sites existed in a closed chromatin conformation in MEFs lacking active histone marks and ATAC-seq signal ( Figures 6A and S7A ). For 111 sites in tr. 13 and 001 sites in tr. 17, O binding correlated with the gain of the enhancer marks H3K4me1/2 and H3K27ac and ATAC-seq signal (Figures 6A and S7A) , suggesting that chromatin opening and selection of these sites is linked to reprogramming factor binding. At 001 sites in tr. 13 PEs, the gain of enhancer marks and chromatin accessibility preceded O binding ( Figure 6A ), implying a role for non-reprogramming TFs in the opening of these sites. Regardless, the transition of PEs from ''closed'' to ''open'' chromatin was associated with the recruitment of Brg1 ( Figure 6B) .
Interestingly, at 111 sites in tr. 13 PEs the level of H3K4me1/2 and H3K27ac was much lower at 48 hr than in pre-iPSCs and ESCs ( Figures 6A and S7A ). This pattern was recapitulated by p300 and Hdac1 binding ( Figure 6B ), demonstrating that reprogramming factor binding at 48 hr induced the selection of these PEs but not their full activation, which occurred at a later reprogramming stage (Figures 6A and 6B) . One intriguing hypothesis is that reprogramming factor binding to PEs early in the process allows for the binding of additional TFs at later reprogramming stages, which is required for full enhancer activation. Regardless, these data showed that the stepwise selection and activation of PEs is largely controlled by parameters beyond chromatin state.
Motif Density and OSK Co-occupancy Distinguish Early and Late-Engaged PEs
Since the chromatin state in MEFs did not distinguish early (111) and late-(001) engaged PEs, we examined properties of the underlying DNA sequence. Early bound O sites in tr. 13 PEs carried significantly more Oct4, Oct4/Sox2 composite, and Klf4 consensus motifs compared to late-bound sites in tr. 13 and 17 ( Figure 6C ). De novo motif scanning also revealed a stronger enrichment of the Klf4 motif in 111 O sites in tr. 13 PEs compared to 001 sites in tr. 17 PEs ( Figure S7B ). Consistent with these differences in motif occurrence, 111 O sites in tr. 13 PEs were cobound by S and K when they were first engaged at 48 hr, whereas tr. 13 and 17 PEs bound by O late (001) were predominantly co-occupied with S but not K in ESCs (Figures 6A and S7C ). These data demonstrated that OSK co-occupancy is associated with PE selection early and OS co-binding with PE engagement late in reprogramming, which is driven by motif presence. Despite co-binding by OSK at 48 hr, 111 O sites in tr. 13 PEs were mostly bound by OS in ESCs ( Figures 6A and S7C ) in agreement with K binding being more distinct to O and S binding in ESCs ( Figures 2E and 2F ) and being influenced by other TFs in ESCs.
PE Engagement Early in Reprogramming Requires
Collaborative Binding by OSK To test mechanistically how the selection of PEs occurs early in reprogramming, we determined the independent ability of O, S, and K to engage these sites at 48 hr. We found that tr. 13 PEs were not targeted when O, S, and K were individually expressed (Figures 6Di, ii, S3B, S3C, and S3G), indicating that the ability of these reprogramming factors to act as pioneer factors is not at play for the opening of these sites. Retroviral co-expression of combinations of reprogramming factors and mapping of binding sites at 48 hr further demonstrated that OSK co-expression was sufficient for the selection of tr. 13 PEs at 48 hr, showing that ectopic M is not essential for PE selection, and additionally revealed lower occupancy when two reprogramming factors were expressed (OS, SK, OK) compared to three (OSK) (Figure 6Diii ). Though these data were consistent with PE section requiring a collaborative mode of action by OSK, one exception was that OS co-expression resulted in binding levels close to those seen with OSK co-expression, particularly for O, despite the lack of ectopic K (Figure 6Diii ). This result likely can be explained by the relocation of endogenously expressed K to these sites in OS-expressing MEFs (Figure 6Diii ). Thus, we conclude that the selection of PEs early in reprogramming requires the collaborative action of O, S, and K and suggest that the necessity of OSK for reprogramming is linked to their ability to open a subset of PEs together.
We made similar observations when considering all sites that were co-occupied by O, S, and K at 48 hr of OSKM-induced reprogramming. Only $30% were accessible to individually expressed O, S, or K, mainly at locations already engaged by endogenous Klf4 in MEFs ( Figure 6E , columns 1-8). The number See also Figure S7 and Tables S5.
of accessible sites increased when double combinations of reprogramming factors were expressed, rising from SK, OK to OS ( Figure 6E , columns 9-15). We also noted that 13.5% of 111 O sites in tr. 13 PEs carried the CEBPA:AP1 composite motif, and that Cebpa, and to lesser extent Cebpb, Fra1, and Runx1, occupied these PEs with OSK at 48 hr ( Figures 6F and 5B) . Additionally, Fra1 extensively engaged tr. 13 PEs early in reprogramming upon overexpression together with the reprogramming factors ( Figure 5I , clusters I, II, and V), further supporting a link between somatic TFs and OSK at PEs. At PEs, somatic TFs may be required for their selection, prevent their activation early in reprogramming, or may simply bind due to the open chromatin character, which will need to be studied further.
Early Engaged PEs Are Close to Core Pluripotency Genes Recently, super enhancers, defined as dense clusters of enhancers with high activity, received attention as cis-regulatory elements of genes that control cell identity (Whyte et al., 2013) . We found that ESC super enhancers gained enhancer marks gradually during reprogramming and that their neighboring genes were activated progressively ( Figures S7D and S7E ). ESC super enhancers were enriched most strongly in tr. 13 PEs ( Figure S7F ) and typically engaged by O, S, and K early in reprogramming (of 231 ESC super enhancers 78% were bound by O; 61% by S; 66% by K at 48 hr) including those at the mir290, Pou5f1, Sox2, Klf4, Tdh1, and Nanog loci ( Figures 6G, S7G , and S7H). Thus, critical regulatory sites of the pluripotent state are among the PEs that are selected early in reprogramming. Interestingly, only a subset of sites within ESC super enhancers bound by O, S, and K in ESCs was engaged at 48 hr ( Figures  6H, 6I , and S7I), suggesting that super enhancers do not act as a single entity and that the opening at specific sites early in reprogramming may be critical for full selection/activation later in the process. Notably, ESC super enhancers represented only a small fraction of all early engaged PEs as only $4% of the 111 O sites in tr. 13 were located within them.
Esrrb Enhances Both ME Inactivation and PE Selection The data described above argue in favor of a model where cooperative binding of TFs, including both reprogramming factors and endogenously expressed TFs, dictates their genomic targeting and thereby enhancer selection. For late-engaged PEs (001 sites), we therefore hypothesized that additional TFs that become available progressively during reprogramming are required for selection either prior to or together with OS. In support of this idea, we observed that in ESCs PEs were occupied by additional TFs that become expressed later in reprogramming, such as Nanog and Esrrb ( Figure 6A ; Table S5 ). Moreover, 001 O sites in PEs could be distinguished from 111 sites by the presence of the Esrrb motif ( Figure 7A ), establishing Esrrb, which is turned on very late in reprograming (Buganim et al., 2012; Pasque et al., 2014; Polo et al., 2012) (Figures S7J and S7K Figure 7C ). 48-hr-specific binding occurred predominantly in promoters, MEs, and transient enhancers ( Figure 7C , group A), whereas ESC-specific sites enriched in PEs ( Figure 7C , group B). 25% of ESC targets of Esrrb became engaged at 48 hr, many of which were located in promoters and, as seen for OSK, in tr. 13 PEs ( Figure 7C , group C). The sites in group C were targeted by O and K in ESCs as well as upon OSKM/Esrrb coexpression at 48 hr, but only a third were engaged by O and K at 48 hr when merely OSKM were overexpressed ( Figure 7C See also Figure S7 and Table S2 .
Interestingly, at 48 hr, tr. 13 PEs reached a similar level of H3K27ac in the presence of Esrrb as reprogramming cells not exposed to Esrrb ( Figure 7D ). However, the average level of H3K27ac was much lower at tr. 5 MEs at 48 hr upon Esrrb expression indicating even more pronounced ME silencing (Figure 7E) . Consistent with this observation, MEF signature genes were more strongly repressed at 48 hr with Esrrb (48 hr E versus 48 hr; Figures 7F, 7G , and S7L). With the exception of a few pluripotency genes such as Nr0b1/2, Tcfcp2l1, and Fut9, Esrrb did not induce precocious expression of ESC-specific genes at 48 hr but instead induced genes involved in metabolic pathways ectopically ( Figures 7H-7J and S7L) . Last, we found that the molecular changes induced by Esrrb early in reprogramming correlated with a more than 100-fold increase in the number of Dppa4 + colonies and shortened kinetics of iPSC-like colony formation ( Figures 7K and 7L ). Together, these data demonstrate a dramatic effect of the pluripotency TF Esrrb on MEF identity, promoting the inactivation of MEs, and, in parallel, on the induction of the pluripotency program by enhancing PE selection.
DISCUSSION
Our study provides a comprehensive analysis of OSKM occupancy at four reprogramming stages. Among the four reprogramming factors, M is distinct as it primarily targets promoters throughout reprogramming, whereas O, S, and K favor enhancers. We found that OSK switch from somatic to pluripotency enhancers during reprogramming and, unexpectedly, orchestrate both the inactivation of MEs and PE selection. Most importantly, our work revealed that the selection of genomic target sites of OSK and the opposing effects on MEs and PEs are controlled by the combinatorial interplay of O, S, and K with endogenously expressed TFs, many with a stage-specific expression.
The extensive silencing of MEs at 48 hr, affecting MEs bound by OSK and those not targeted by the reprogramming factors, was a particularly surprising finding and indicated the widespread interference with the somatic epigenetic network very early in reprogramming. We determined that OSK initiate the silencing of MEs by at least three distinct mechanisms: first, OSK bind to approximately 50% of the most active MEs and increase their Hdac1 levels, potentially attributable to the interaction of Hdac1 with Oct4 (Pardo et al., 2010) (Figure 7Mi ). Second, OSK induce the removal of somatic TFs from OSK-bound and unbound MEs (Figure 7Mi and Mii). Mechanistically, the loss of somatic TFs from MEs is accomplished by their relocation away from MEs to new sites including PEs that become bound by OSK at 48 hr and carry the motifs for the reprogramming factors and the somatic TFs (Figure 7Miii ). Third, OSK expression leads to a decrease in Fra1 transcript levels, which contributes to the extensive loss of this TF from MEs (Figure 7Miv ).
Binding sites in MEs contained fewer consensus DNA binding motifs of each reprogramming factor than those at PEs, suggesting that the interaction of OSK with MEs differs from that at PEs. In addition to MEs, OSK engage a substantial number of PEs at 48 hr including sites in super enhancers neighboring critical pluripotency-associated genes (Figure 7Ni) . However, the majority of PEs are bound only at later stages (Figure 7Nii ), revealing that PEs selection is a stepwise process. The different kinetics of PE selection was not explainable by differences in the chromatin state in starting MEFs. Instead, we propose that the timing of PE selection is dictated by (1) the collaborative binding among O, S, and K, and with additional, endogenously expressed TFs, and (2) cis-encoded properties, i.e., the presence and combination of motifs at these sites ( Figure 7N) . O, S, and K together, potentially with somatic TFs, are required for the opening of PEs early in reprogramming (Figure 7Ni ), which perhaps explains why this combination of reprogramming factors is so successful in establishing pluripotency. At early engaged PEs, opening by OSK does not result in strong enhancer activation at 48 hr, which likely requires other TFs that become available later. Conversely, late-engaged PEs are targeted by OS, without K, indicating that OS alone are not sufficient to effectively compete with nucleosomes at these sites early in reprogramming (Figure 7Nii) . Here, additional TFs that only become available later, such as Esrrb, are required for their selection in concert with OS (Figure 7Nii ).
Ectopic Esrrb not only influenced OSK binding at PEs, but also bound MEs and facilitated their silencing. Equally, Fra1 acted on both MEs and PEs when overexpressed. Thus, stage-specific TFs, including both somatic and pluripotency TFs, influence OSK binding, ME silencing, and PE selection, reinforcing the idea of the combinatorial control of TF binding during reprogramming. These observations and the fact that targeting of PEs in closed chromatin require binding of multiple TFs indicate that the pioneer factor model proposed for human somatic cell reprogramming (Soufi et al., 2012 (Soufi et al., , 2015 does not act at enhancers in mouse cell reprogramming. Additional work will be required to understand the differences between reprogramming processes in different species.
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STAR+METHODS KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat monoclonal anti-Nanog eBioscience Cat#14-5761-80
Rabbit polyclonal anti-Nanog cosmobio Cat#REC-RCAB001P
Goat polyclonal anti-DPPA4 R&D Cat#AF3730
Goat polyclonal anti-Oct4 RnD Cat#AF1759
Goat polyclonal anti-Sox2 RnD Cat#AF2018
Goat polyclonal anti-Klf4 RnD Cat#AF3158
Goat polyclonal anti-cMyc RnD Cat#AF3158
Mouse monoclonal anti-Esrrb RnD Cat#H6705
Rabbit polyclonal anti-H3K9ac Abcam Cat#ab4441
Rabbit polyclonal anti-H3K4me3 Abcam Cat#ab8580
Rabbit polyclonal anti-H3K4me2 Abcam Cat#ab7766
Rabbit polyclonal anti-H3K4me1 Abcam Cat#ab8895
Rabbit polyclonal anti-H3K27me3 Active Motif Cat#39155
Rabbit polyclonal anti-H3K27ac Abcam Cat#ab4729
Rabbit polyclonal anti-H3K36me3 Abcam Cat#ab9050
Rabbit polyclonal anti-H3K79me2 Active Motif Cat#39143
Rabbit polyclonal anti-H3K9me3 Abcam Cat#ab8898
Mouse 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The Chancellor's Animal Research Committee at University of California Los Angeles has approved our animal breeding and research protocols. Animals were used for isolating cultures of primary cells from mice. Mouse embryonic fibroblasts (MEFs) harboring the M2rtTA construct in the R26 locus (heterozygously) together with a single dox-inducible polycistronic cassette coding for OSKM in the Col1A locus (tetO-OSKM) (Ho et al., 2013; Sridharan et al., 2013) or a dox-inducible cassette encoding a single reprogramming factor (tetO-Oct4, tetO-Sox2, or tetO-Klf4) in the Col1A locus, or wild-type MEFs were used for reprogramming experiments, ChIPseq, ATAC-seq, and RNA-seq assays. In addition, pre-iPSCs derived by retroviral overexpression of OSKM in MEFs and the mouse ESC line V6.5 were used to study different stages of reprogramming. All cell lines are described in the Key Resources Table. METHOD DETAILS
Cell lines, culture conditions, and reprogramming experiments
The following cell lines were used for the comprehensive genomics analysis of the reprogramming process at discrete stages: primary MEFs harboring a heterozygous R26-M2rtTA allele and a single dox-inducible polycistronic cassette coding for OSKM in the Col1A locus (tetO-OSKM) (Ho et al., 2013; Sridharan et al., 2013) , derived from day 13.5 embryos of timed mouse pregnancies; two independently generated male pre-iPSC lines (line 12-1 (pre-i #1 ) and 1A2 (pre-i #2 ) obtained upon retroviral (pMX-based) expression of Oct4, Sox2, Klf4, and cMyc in Nanog-GFP reporter MEFs (Sridharan et al., 2009 (Sridharan et al., , 2013 ; and the male ESC line V6.5 from the Jaenisch laboratory. All cell types were grown in standard mouse ESC media containing KO DMEM, 15% fetal bovine serum (FBS), recombinant leukemia inhibitory factor (Lif), b-mercaptoethanol, 1x penicillin/streptomycin, L-glutamine, and non-essential amino acids. PreiPSCs and ESCs were grown on irradiated MEFs (feeders), but feeder-depleted and grown overnight on gelatin for genomics experiment. For the 48h reprogramming time point, tetO-OSKM MEFs were cultured in ESC media containing 2 mg/ml doxycycline for 48 hr to induce the expression of OSKM. For all ChIP-seq, ATAC-seq and RNA-seq experiments, cells were grown in ESC medium.
For single reprogramming factor overexpression ChIP-seq experiments ( Figures 2G, 4J , 4K, 6D, 6E, S3, and S5H), MEFs containing a dox-inducible cassette encoding a single reprogramming factor (tetO-Oct4, tetO-Sox2, or tetO-Klf4) in the Col1A locus and the tet-transactivator M2rtTA in the R26 locus (heterozygous) were generated as described (Beard et al., 2006) by targeting V6.5 ESCs carrying a FRT site in the Col1A locus, generating chimeric mice upon blastocyst injection, and breeding for germline transmission. These MEFs were induced with 2ug/ml doxycycline for 48h to assess the binding events of individually expressed reprogramming factors. Alternatively, wild-type 129SVJae MEFs were infected with a pMX retrovirus encoding an individual reprogramming factor (either pMX-Oct4, pMX-Sox2, or pMX-Klf4) for single factor overexpression, or with a combination of reprogramming factor baring retroviruses for double or triple reprogramming factor combinations (OK, SK, OS, or OSK). Briefly, the cDNAs of the three factors (Oct4, Sox2 or Klf4) were cloned into the pMX retroviral vectors and individually transfected into PlatE packaging cells (Maherali et al., 2007) . Viral supernatants were harvested 48 hr post-infection and used to infect MEFs twice, for 8hrs continuously in the presence of 10 mg/ml polybrene. MEFs were harvested for genomics analyses 48 hr post infection.
The role of somatic TFs in the reprogramming process was tested via overexpression by infecting tetO-OSKM MEFs with pMXretroviruses encoding the Fra1, cJun, or Runx1 cDNA. N-terminally Flag-tagged versions of cJun and Fra1 were also cloned into pMX vectors and tested for reprogramming efficiency. Viral supernatants were produced in platE cells as described above.
Subsequently, tetO-OSKM MEFs were infected twice for a span of 8 hr each time, followed by dox-induction of OSKM expression. For Esrrb overexpression, a lentiviral construct encoding the tet-inducible Essrb cDNA, obtained from (Buganim et al., 2014) , was transfected alongside viral packaging vectors (pMDLg, pRSV-REV, pCMV-VSVG) into 293T cells using the CalPhos mammalian transfection kit (Clontech 062013) as per manufacturer's instructions. Lentiviral production was performed for 48h, and the harvested supernatant used to infect tetO-OSKM MEFs containing M2rtTA twice. To initiate reprogramming and Esrrb expression, the cells were cultured in ESC medium containing 2mg/ml doxycycline. The viral packaging vectors were a generous gift from Dr Zack laboratory in UCLA.
For the Runx1, Cebpa and Cebpb siRNA experiments, a set of four different siRNAs was purchased from Dharmacon and initially transfected into MEFs using lipofectamine-RNAi max (Life Technologies) according to manufacturer's instructions to assess knockdown efficiency. Of the four siRNAs, the two producing the most efficient knockdown were used in reprogramming experiments at a final concentration of 20uM. For Runx1 these were D-048982-01 and D-048982-03, for Cebpa D-040561-03 and D-040561-04, and for Cebpb D-043110-06 and D-043110-22. For control siRNA treatment, we used the non-targeting Luciferase control (D-001210-02) . siRNAs against Runx1 were transfected into tetO-OSKM MEFs two times: first 12 hr before reprogramming was started by doxycycline addition, and second at the time of doxycycline addition, to induce depletion of Runx1 only early in reprogramming. siRNAs against Cebpa/b were first transfected 12 hr before reprogramming was started by doxycycline addition and were re-transfected every three days to maintain knockdown throughout reprogramming.
In all experiments that assessed reprogramming efficiency, reprogramming cultures were shifted to reprogramming media, which is similar to ESC medium but contains 15% KSR instead of FBS, at day 3 of reprogramming. Reprogramming efficiency was scored by counting Nanog-positive colonies after immunostaining cultures with an anti-Nanog antibody (eBioscience 14-5761-80), 11 days post doxycycline induction. For the Runx1 siRNA experiment, doxycyline was withdrawn from the cultures at day 9, for the last 48 hr, before fixation of the reprogramming cultures at day 11. For OSKM/Esrrb-induced reprogramming cultures reprogramming efficiency was calculated by counting DPPA4-positive colonies after immunostaining with an antibody directed against DPPA4 (R&D AF3730), 8 days post-OSKM/E induction with doxycycline. We have shown previously that DPPA4 is induced after Nanog expression during the final steps of reprogramming (Pasque et al., 2014) .
Immunofluorescence Cells were grown on coverslips pretreated with 0.3% porcine gelatin (Sigma G2500) in ESC medium for 48h. After fixation with 4% paraformaldehyde the cells were washed with 1xPBS-0.05% Tween, permeabilized with 1xPBS-0.5% Triton-X, and blocked with 5% donkey serum in 1xPBS-0.05% Tween. Primary antibody incubation was carried out at 4 C overnight, secondary antibody incubation was carried out at RT for 30min, each in blocking buffer. Between each incubation, cells were washed with 1xPBS-0.05% Tween for three times. Cells were then mounted using a mounting medium with DAPI (Vector Labs H-1200). Antibodies used for Nanog and DPPA4 to detect reprogrammed colonies are listed above. Antibodies for the detection of O,S,K,M or Esrrb were: anti-Oct4 (RnD; AF1759), anti-Sox2 (RnD AF2018), anti-Klf4 (RnD; AF3158), anti-cMyc (RnD; AF3158) and anti-Esrrb (RnD; H6705).
Native ChIP-seq (N-ChIP) Native ChIP-seq was performed for as described in (Wagschal et al., 2007) for all histone modification except H3K79me2 and H3K9me3. Briefly, 50 3 10 6 Nuclei were isolated from non-crosslinked cells (MEFs, 48h, pre-i #1 and ESC) by incubation in 2 mL of a hypotonic solution (0.3M sucrose, 60mM KCl, 15mM NaCl, 5mM MgCl 2 , 15mM Tris-HCl pH 7.5, 0.5mM DTT, 0.1% NP40, and protease inhibitor cocktail) followed by centrifugation through a sucrose cushion (1.2M sucrose, 60mM KCL, 15mM NaCl, 5mM MgCl 2 , 0.1mM EGTA, 15 mM Tris-HCl pH 7.5, 0.5mM DTT, and protease inhibitor cocktail). Nuclei were then re-suspended in MNAse-digestion buffer (0.32M sucrose, 50mM Tris-HCl pH 7.5, 4mM MgCl 2 , 1mM CaCl 2 , and protease inhibitor cocktail) and digested with 3 units of MNase (Roche 10107921001) for 10 min at 37 C. The first soluble fraction (S1) was recovered by centrifugation for 10 min at 10,000 rpm. The pellet containing nuclei was then dialyzed overnight in 1l of dialysis buffer (1mM Tris-HCl pH7.5, 0.2mM EDTA, protease inhibitors) to more completely release the chromatin fraction (S2) from nuclei. 10 ug of soluble chromatin (S1 and S2) were then incubated with 5 ug of antibody targeting histone modifications-conjugated to magnetic beads (Active Motif; 53014) under constant stirring at 4 C for 16 hr. The antibodies used were: anti-H3K9ac (Abcam; ab4441), anti-H3K4me3 (Abcam; ab8580), anti-H3K4me2 (Abcam ab7766), anti-H3K4me1 (Abcam; ab8895), anti-H3K27me3 (Active Motif; 39155), antiH3K27ac (Abcam; ab4729), and anti-H3K36me3 (Abcam; ab9050). Beads were washed twice with wash buffer A (50mM TrisHCl pH 7.5, 10mM EDTA, 75mM NaCl), wash buffer B (50mM Tris-HCl pH 7.5, 10mM EDTA, 125mM NaCl), and wash buffer C (50mM Tris-HCl pH 7.5, 10mM EDTA, 175 mM NaCl). DNA was extracted using phenol:chloroform:iso-amylacohol and used for downstream library construction. DNA from fractions S1 and S2 was also isolated directly using phenol:chloroform:iso-amylacohol extraction and used as an whole genome input control (native Input). All protocols for Illumina/Solexa sequencing library preparation, sequencing, and quality control were performed as recommended by Illumina, with the minor modification of limiting the PCR amplification step to 10 cycles. All constructed libraries were sequenced using single-end 50 bp reactions.
Cross-linked ChIP-seq (X-ChIP) Transcription factor and epigenetic regulator occupancy data generated in this study were acquired using ChIP after crosslinking cells (X-Chip). X-ChIP was also employed for mapping H3K79me2 (Active Motif, 39143), H3K9me3 (abcam, ab8898 or Millipore, 05-1242), H3 (abcam, ab1791) and H3.3 (Abnova, H00003021-M01). Briefly, cells were grown to a final concentration of 5x10 7 cells for each ChIP-seq experiment. To stabilize HATs/HDACs (p300, Hdac1) and Brg1 on chromatin, cells were treated with 2 mM disuccinimidyl glutarate (DSG) for 10 min prior to formaldehyde crosslinking. For all other targets, cells were chemically cross-linked at room temperature by the addition of formaldehyde to 1% final concentration for 10 min and quenched with 0.125 M final concentration glycine. Cross-linked cells were re-suspended in sonication buffer (50mM HEPES-KOH pH 7.5, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS) and sonicated using a Diagenode Bioruptor for three 10 min rounds using pulsing settings (30 s ON; 1 min OFF). 10 ug of sonicated chromatin was then incubated overnight at 4 C with 5 ug of antibody conjugated to magnetic beads. The antibodies used were: anti-Esrrb (RnD; H6705), anti-Klf4 (RnD; AF3158), anti-cMyc (RnD; AF3696), antiNanog (cosmobio REC-RCAB001P), anti-Oct4 (RnD; AF1759), anti-Sox2 (RnD AF2018), anti-p300 (SantaCruz;sc-585), anti-Runx1 (Novus Biologicals NBP1-61277), anti-Fra1 (SantaCruz;sc-183X), anti-Cebpa (SantaCruz; sc-61X), anti-Cebpb (SantaCruz;sc-150X), anti-Hdac1(abcam; ab7028) and anti-Brg1(abcam; ab110641). Following the IP, beads were washed twice with RIPA buffer (50mM Tris-HCl pH8, 150 mM NaCl, 2mM EDTA, 1% NP-40, 0.1% Na-deocycholate, 0.1% SDS), low salt buffer (20mM Tris pH 8.1, 150mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1% SDS), high salt buffer (20mM Tris pH 8.1, 500mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1% SDS), LiCl buffer (10mM Tris pH 8.1, 250mM LiCl, 1mM EDTA, 1% Na-deoxycholate, 1% NP-40), and 1xTE. Finally, DNA was extracted by reverse crosslinking at 60 C overnight with proteinase K (20ug/ul) and 1% SDS followed by phenol: chloroform:iso-amylacohol purification. Libraries were constructed as indicated above and sequenced using single-end 50 bp reactions.
ATAC-seq library construction and sequencing ATAC-seq was done as previously described (Buenrostro et al., 2013) . Briefly, 50000 cells (129SVJae MEFs, un-induced tetO-OSKM MEFs, 48h OSKM , pre-i #1 , pre-i #2 or ESCs) were re-suspended in 50 mL lysis buffer (10 mM Tris pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% NP40, and 1 3 Complete Protease inhibitor (Roche)) and spun at 500g for 10 min at 4 C to collect nuclei. Nuclei were washed in 1x PBS and subsequently re-suspended in 50 ml Transposase reaction (25 ml 2 3 tagmentation buffer, 22.5 ml water, 2.5 ml Tn5 Transposase, following instructions by Illumina). Reactions were incubated for 30 min at 37 C and DNA purified using QIAGEN MinElute columns (QIAGEN). The transposed DNA was subsequently amplified with custom primers as described (Buenrostro et al., 2013) for 7-9 cycles and libraries were visualized on a 2% TBE gel prior to sequencing with a single-end-sequencing length of 50 nucleotides.
RNA-seq
RNA from independent biological replicates of each un-induced MEFs, induced MEFs at 48hrs, pre-iPSCs (pre-i #1 & pre-i #2 ) and ESCs, was isolated using the RNeasy Mini kit. RNA was treated on column with 0.5 kunitz units of DNase prior to elution according to manufacturers instructions. RNA from MEF cultures induced for 48h to express OSKM/Esrrb, OSKM/Fra1, OSKM/cJun or a single reprogramming factor (tetO-Oct4, tetO-Sox2, or tetO-Klf4, tetO-Myc) was also isolated. In all cases, messenger RNA was captured using oligodT Dynabeads (Life Technologies). Strand-specific RNA-seq libraries were constructed as described in (Parkhomchuk et al., 2009) .
QUANTIFICATION AND STATISTICAL ANALYSIS Data Analysis and Visualization
Reads from ChIP-seq experiments were mapped to the mouse genome (mm9) using Bowtie software (Langmead et al., 2009 ) and only those reads that aligned to a unique position with no more than two sequence mismatches were retained for further analysis. Multiple reads mapping to the exact same location and strand in the genome were collapsed to a single read to account for clonal amplification effects. For ChIP-seq of TFs and ATAC-seq, peaks were called using MACS2 software (Zhang et al., 2008 ) using a bandwidth parameter of 150bp. Peaks with q-val cut-off < 0.005 and fold > = 4-fold were retained. Identified peak locations can be found in Table S1 .
Reads from RNA-seq experiments were mapped to the mouse genome (mm9) using TopHat software (Trapnell et al., 2009 ) and only those reads that aligned with no more than two sequence mismatches were retained. Replicates were merged and RPKM values of mm9 RefSeq genes were calculated as described (Mortazavi et al., 2008) (Table S2 ). Prior to log2 transformation of RPKM values, a pseudo-count of 1 was added to all RPKM values (log2(RPKM+1).
Genome signal tracks of features (TFs, histone marks, ATAC-seq and RNA-seq) were calculated by partitioning the genome into non-overlapping bins of fixed size (100b for TFs, ATAC-seq and RNA-seq, and 25bp for the histone marks). RPKM values were calculated for each bin using the number of sequencing reads that overlap with the corresponding bin. For histone marks, each read was extended by 200 bp in the direction of the alignment. Tracks were visualized in the IGV genome browser (Thorvaldsdó ttir et al., 2013) .
To produce the heatmaps, in Figures 2C, 2G , S2D, S2E, S3A, S3D, S3F, 4A, 4E, 6A, 6D-6F, S6C, and 7C, we aligned the given feature (such as peaks of a TF) at their summit and tiled the flanking up-and downstream regions within ± 2kb in 100bp bins. For each location, we calculated RPKM values over all 100bp bins by using the number of sequencing reads that overlap each bin after extension by 200bp in the direction of the alignment. To control for input, we computed at each bin a log 2 input-normalized RPKM value as log 2 (RPKM FOREGROUND ) -log 2 (RPKM Input ), where RPKM FOREGROUND denotes the RPKM of the corresponding TF or histone dataset and RPKM Input denotes the RPKM value of the corresponding whole genome 'Input'. For visualization in figures, each 100 bp bin was displayed with JavaTreeview (Eisen et al., 1998) . All metaplots were produced by computing the average input-normalized RPKM value for each 100bp bin across all locations in the given set.
The scatterplots in Figures 5G, S6D , and S6E were produced by first computing log 2 (RPKM+1) values over 200bp windows centered at each binding site for the TF signal in MEFs and 48h. To control for the input, we computed log 2 (RPKM+1) for the input signal in MEFs at each 200bp window and subtracted it from the values in MEFs and 48h to obtain an input-normalized log 2 RPKM value for each cell type: log 2 (RPKM TF in X +1) -log 2 (RPKM MEF_Input +1), where RPKM TF in X is the RPKM value in MEF or 48h.
Figures S7D and S7I were generated with ngs.plot (Shen et al., 2014) .
ChIP-seq and ATAC-seq data validation Several external (published) datasets were used to validate our ChIP-seq data (Table S3) . Moreover, the majority of ChIP-seq datasets in this study were generated in biological replicates (Table S3) , and the correlation of replicate datasets demonstrated a high reproducibility of our data. Furthermore, to ensure that un-induced (starting) tetO-OSKM MEFs were not already representing a 'leaky' expression state for the reprogramming factors (already partially reprogrammed), we also profiled wild-type MEFs not carrying any reprogramming factor transgene for ATAC-seq. These ATAC-seq datasets correlated most closely with those of the un-induced tetO-OSKM MEFs.
Correlation of our datasets with imputated datasets
We created an imputed version of the H3, H3.3, H3K27ac, H3K27me3, H3K36me3, H3K4me1, H3K4me2, H3K4me3, H3K79me2, H3K9ac, H3K9me3, p300, ATAC-seq and INPUT (Native Input) data for MEFs, 48h, pre-i #1 , and ESCs, using ChromImpute v1.0.0 (Ernst and Kellis, 2015) . In creating the imputed version of a dataset, we used all other datasets but the dataset being imputed. The imputed version of each dataset can be viewed as a pseudo-replicate for each dataset and can be used to assess reproducibility. The data put into ChromImpute were the RPKM normalized signals at 25bp resolution after removing reads that map to blacklisted regions in the mouse genome (https://sites.google.com/site/anshulkundaje/projects/blacklists; ENCODE Project Consortium, 2012) and excluding chrM. The signal files for all histone marks, H3, H3.3, and INPUT were generated by extending reads by 200bp in the direction of the alignment. The signal for p300 and ATAC-seq was generated without extension of the reads. ChromImpute was run with default options except the flag '-b 20 -tieglobal' was added to the GenerateTrainData command, the flag '-b 20' to the Train command, and the flag '-b 20 -tieglobal' to the Apply command. The imputed data were converted to a 1000bp resolution by averaging the signal for each 25bp within it. Signal tracks for the observed data were produced at 1000bp resolution in the same way as the signal at 25bp used as input for ChromImpute. Pairwise Pearson correlations were then computed based on the 1000-bp resolution data (Table S3 ). For each observed dataset, we also reported the maximum correlation with any of the other three observed datasets (for the other reprogramming stages) for the mark based on the 1000-bp resolution data (Table S3) . HTSeq (Anders et al., 2015) was used to determine gene counts from replicate experiments, and DESeq2 (Anders and Huber, 2010) for differential analysis. Our quadruplicate datasets were used to identify differential genes between MEFs and OSKM-induced MEFs at 48h (48h), using an adjusted p value < 0.05. DESeq2 was also used to identify differential genes from the following comparisons 1) OSKM-induced MEFs at 48h against and OSKM/Esrrb-induced MEFs at 48h; 2) OSKM-induced MEFs at 48h against and OSKM/ Fra1-induced MEFs at 48h; and 3) OSKM-induced MEFs at 48h against and OSKM/cJun-induced MEFs at 48h. In addition, genes were called MEF-or ESC-specific using the following criteria: 1) DESeq2 differential calls with an adjusted p value < 0.05 between ESCs and MEFs; 2) Fold-change of > = 5x between transcript levels in MEFs and ESCs; 3) low RPKM value of in the non-expressing type (typically < 1 RPKM).
Differential gene expression analysis
Defining combinatorial OSKM binding groups per reprogramming stage
We generated sets of sites co-bound by the reprogramming factors at a given reprogramming stage by extending TF summits produced by MACS2 by 100 bp in each direction and intersecting the extended summits between Oct4, Sox2, Klf4, and cMyc per reprogramming stage ( Figure 2F ). In this case, we first defined sites bound by all four TFs by intersecting the extended summits of all four factors in any possible order and merging overlapping intersections. Analogously, we defined triply bound sites, and, subsequently, removed those regions that overlapped with the quadruply bound sites from them. Next, we defined doubly bound sites by intersecting the extended summits of every pair of TFs and removing regions that overlapped triply and quadruply bound sites. Finally, we defined solo bound sites as all sites that were not doubly, triply, or quadruply bound. To calculate the enrichment scores of the co-bound groups in Figure 2Fii , we used the middle point between the start and the end coordinates of quadruply, triply, and doubly bound sites. For solo sites, the coordinates of the original summits were used.
Determination of temporal OSKM binding groups
Seven co-binding groups ( Figure 2D : '100', '010', '001', '110', '011', '101', '111') were generated in a similar manner as the combinatorial OSKM binding groups described above, by intersecting the extended TF summits (100bp) of a given TF among the three reprogramming stages: 48h, pre-i #1 , and ESCs.
Transcription factor clusters K-means clustering was employed to identify coherent groups of TF binding in Figures S2J, 5C , and 5I. To define these TF clusters, the genome was tiled into 500bp windows and the presence of TF peaks in each bin was determined. This procedure resulted in a vector of binary data for each TF reflecting its absence or presence within 500bp windows across the genome. The windows represented by these vectors were then clustered using R's k-means function applying the Hartigan-Wong method to obtain groups of windows exhibiting common combinatorial binding patterns across the genome. The number of clusters was chosen to reduce the number of potential combinatorial TF groups, while ensuring that each cluster was represented by a significant number of windows.
Ontology Annotation
To associate transcription factor peaks with the closest gene for Ontology analysis ( Figures S2G, S4C , and S4E; Table S4 ) we used the GREAT tool (McLean et al., 2010) with default parameters. Differentially regulated genes defined by DESeq2 ( Figures 5J, S6F , S6G, and S7L) were assigned to relevant GO ontology groups using the Metascape software (Tripathi et al., 2015) .
ChromHMM modeling parameters
To derive chromatin state segmentations for each reprogramming stage ( Figure 1C ), we used ChromHMM (version V1.1.0) (Ernst and Kellis, 2012) with default parameters. First, we binarized the mapped reads for all chromatin marks and the native 'Input' indicated in Figure 1C with the ChromHMM's BinarizeBed procedure, using a p value cutoff of 1e-4. To reduce effects of artifacts, we removed redundancy in the input data by keeping only one sequencing read in cases where multiple reads mapped to the same genomic position and strand orientation. We examined models with different numbers of states ranging from 2 to 30 and chose a model with 18 chromatin states that is both interpretable and able to capture the combinatorial complexity of chromatin marks in each reprogramming stage. In addition to the 18 chromatin state model shown in Figure 1C , which captures chromatin states per reprogramming stage, we used ChromHMM in the ''stacked'' mode to capture the chromatin changes between MEFs, 48h, pre-iPSCs (pre-i #1 ), and the pluripotent state, which yielded the 35 chromatin trajectories defined in Figure 3A . In particular, we constructed a single virtual cell type that has all datasets from MEFs, 48h, pre-i #1 , and ESCs as individual marks by setting the label of each original dataset in the input file for ChromHMM to contain both the source cell type and the histone mark name. Then, we used ChromHMM to discover and annotate the genome for chromatin states in the virtual cell type. The rest of the preprocessing and ChromHMM parameters were the same as for the 18 state model described above. We considered models with different numbers of states ranging from 25 to 100 and chose 35 states, because it was the model with the minimum number of states that captured unique biological events. We termed the resulting 35 chromatin states ( Figure 3A ) ''chromatin trajectories'' to distinguish them from the chromatin states specific to each reprogramming stage ( Figure 1C ).
TF enrichment in the vicinity of differentially expressed genes early in reprogramming ( Figures S6H and S6I ) OSKM binding combinations and groups of MEF-only, 48h-only, and shared somatic TF binding events were intersected with the genomic intervals encompassing TSS+/À 20kb regions of differentially expressed genes at 48h. To compute the fraction of bound upregulated genes for each type of TF set, we counted the number of upregulated genes between MEFs and 48h that have at least one such binding event within 20kb of their TSS and divided this number by the total number of upregulated genes between MEFs and 48h. Analogously, we computed the fraction of bound downregulated genes between MEF and 48h for each TF combination. We then divided the two fractions and plotted the ratio on log2 scale. The statistical significance of each log2 ratio was assessed by a chisquare test that compares the number of TF bound genes between the two groups given the total number of genes in each group.
Positional expression plots (Figures S1H and S4B)
For each chromatin state, we calculated average gene expression levels in MEFs, 48h, pre-i #1 , and ESCs, conditioned on the state's distance from annotated transcription start sites. We restricted this analysis to 50kb up-or downstream of transcriptional start sites (TSS). We partitioned this region into non-overlapping bins of 200 bp. For each bin, we computed the average log2 (RPKM+1) value of genes that have a particular chromatin state at this distance relative to their TSS.
Calculations of fold-enrichment
Using the ChromHMM OverlapEnrichment function (Ernst and Kellis, 2012), we calculated enrichment scores for genomic features (TF binding events, conserved elements, repeats, exon, gene-bodies, TSS, TES, ESC super enhancers, etc) in the chromatin state of each corresponding reprogramming stage (18-state chromatin model) and for the 35 chromatin trajectories capturing the chromatin changes during reprogramming, respectively. The enrichment scores were calculated as the ratio between the observed and the expected overlap for each feature and chromatin state based on their sizes and the size of the mouse genome:
where F is the number of base pairs annotated for the feature F, S is the size of chromatin state S and G is the total length of the mouse genome.
To calculate log2 differential enrichments in Figure 2Fii , we used the following formula:
log 2 Enrichment in cell type A Enrichment in cell type B where each enrichment is calculated based on a binomial background model that treats the corresponding TFs as independent in each cell type (48h and ESCs).
Coordinates for TSS, TES, CpG islands, Exon and Gene Body features used were part of the mm9 annotation included in the ChromHMM software (Ernst and Kellis, 2012) . For the calculation of enrichments of conserved genomic regions in Figures 1D and S1G, we downloaded the 30-way Euarch phastCons elements from the UCSC genome browser for the mm9 genome that represent 30 vertebrate species (euarchontoglires) including human and mouse (Siepel et al., 2005) .
In Figures 2E and S2I , we applied complete linkage hierarchical clustering with optimal leaf ordering to cluster the enrichments of all pairs of TFs (Bar-Joseph et al., 2001 ). The pairwise enrichments at base-pair resolution were calculated as the observed overlap divided by the expected overlap based on the binomial background model that treats both transcription factors as independent:
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where the numerator is the size of the overlap between peaks of TF A and TF B and the denominator is the product between the total number of bp occupied by peaks of TF A and TF B divided by the size of the genome (G) . A pseudo-count of 100 was added to both the numerator and the denominator to avoid instabilities due to division of small numbers and the maximum enrichment was set to 500. In Figure 3Bii , the fold-enrichment of the 35 chromatin trajectories in the vicinity of MEF-and ESC-specific genes was calculated with the following formula: % Cell type A specific genes with trajectory i within TSS ± 20kb % Cell type A active genes with trajectory i within TSS ± 20kb where the numerator is the percentage of genes (MEF-or ESC-specific; as described above and Table S2 ) carrying each trajectory i within 20kb from their TSS. As control, we divided by the percentage of all active genes in the same cell type (> 1 RPKM) carrying that trajectory.
Assigning peaks to TSS (+/À2Kb) regions
We computed the proportion of transcription factor binding summits of Oct4, Sox2, Klf4, and cMyc that are located within 2 kb of annotated transcription start sites (mm9 RefSeq TSS) and the rest (distal). p values in Figures 2A and S2A were calculated based on an exact two-sided Binomial test of the null hypothesis that the probability of TSS in one of the samples is given by the frequency in the other sample.
Motif analyses
We calculated motif densities at 10 bp resolution within 500 bp around ChIP-seq summits by using the annotatePeaks procedure from HOMER (Heinz et al., 2010) with the following command line arguments: annotatePeaks.pl mm9 -size -500,500 -hist 10
We used the positional weight matrices for the corresponding transcription factor binding motifs provided by HOMER with their default thresholds.
When we scanned regions that were bound by multiple transcription factors, we centered each region at the summit of the corresponding TF. For example, regions co-bound by OSKM were centered at the corresponding Oct4 summits when we scanned them for the Oct4 motif, then centered at the Sox2 summits for the Sox2 motif, then centered at the Klf4 summits for Klf4 motif, and, finally, centered at the cMyc summits for the cMyc motif.
We subsequently smoothed the motif densities by applying a box kernel of length 5 bins centered at each bin. To calculate confidence intervals at the summit bin, we generated 1000 bootstrap samples within each group and calculated the 95% percentile bootstrap confidence intervals (Efron and Tibshirani, 1991) .
For de novo motif discovery we used the findMotifsGenome.pl procedure from Homer using the following arguments. findMotifsGenome.pl mm9 -size 200 -mask -cache 1000
DATA AND SOFTWARE AVAILABILITY
The accession number for the genomics data reported in this paper is GEO: GSE90895.
Peak locations derived from ChIP-seq and ATAC-seq experiments are given in Table S1 , and normalized expression measurements based on RNA-seq are given in Table S2 . . In addition, the data for O, S, and K occupancy in pre-i #1 and the independent pre-iPSC line pre-i #2 are shown for the same sites, indicating extensive co-binding of O, S, and K with Cebpb in pre-iPSC lines. (D) Scatterplot of input normalized ChIP-seq signal (log 2 (RPKM+1) of Runx1 for MEF-only (green), 48h-only (blue), and shared (red) Runx1 binding events defined in (A) . (E) As in (D) , except for Fra1 at sites defined in (B) . (F) Expression changes early in reprogramming. 609 genes (adjusted p value < 0.05) were differentially regulated within the first 48h of OSKM induction based on RNA-seq, with 372 genes induced and 237 genes downregulated (Table S2 ). Transcription levels of these up-and downregulated genes in MEFs and at 48h of reprogramming are represented as boxplots. (G) Gene ontology groups associated with up and downregulated genes defined in (F) . (H) Differential enrichment of OSKM co-binding events in genes up-and downregulated early in reprogramming as defined in (F) . We computed the log2 ratio between the fraction of bound downregulated genes out of all downregulated genes and the fraction of bound upregulated genes out of all upregulated genes for different combinations of OSKM binding. Bound genes were defined as genes that have at least one binding site of the corresponding combination within 20kb of their TSS. Blue and red coloring represent higher fractions in down-and upregulated genes, respectively. Only the enrichment of the OSK co-binding event was significant (*; p < 0.01 Chi-square test) indicating that sites co-occupied by O, S, and K are enriched in upregulated genes.
(I) As in (H) , but showing the differential enrichment of MEF-only, 48h-only, and shared binding events of Cebpa, Cebpb, Fra1, and Runx1 as defined in Figures 5A , S6A, and S6B in genes up-and downregulated early in reprogramming. These data demonstrate that upregulated genes carry more 48h-only somatic TF binding events compared to downregulated genes whereas higher fractions of downregulated genes are occupied by MEF-only somatic TF binding relative to upregulated genes. * denotes significance (p < 0.01 Chi-square test).
(J) Transcript levels of the somatic TFs Fra1, Cebpa, Cepbb, and Runx1 in MEFs, 48h, pre-i #1 , pre-i #2 , and ESCs, based on RNA-seq data. (F) Fold-enrichment of the 35 chromatin trajectory described in Figure 3A within ESC super enhancers colored within the column from highest (blue) to lowest (white). (G) Snapshot of 48h and ESC O, S, and K ChIP-seq data (RPKM) at the ESC super enhancer regions associated with the Nanog, Sox2, Oct4, and Klf4 genes. In addition, the chromatin changes of these region are given by the trajectory annotation (from the 35 chromatin state model) based on the color-code in Figure S4A . Sites bound by O, S, or K already at 48h are highlighted by the gray shading. (H) Genome browser view of O, S, and K ChIP-seq data and ATAC-seq data at the Tdh1 ESC super enhancer (RPKM) at the indicated reprogramming stages. In addition, the chromatin changes of this region are given by the trajectory annotation (from the 35 chromatin state model) based on the color code in Figure S4A . Of the five major sites in this super enhancer bound by O, S, or K in ESCs (highlighted by gray bars), one is engaged already at 48h (labeled with 1) and the others are bound only at later reprogramming stages (labeled with asterisks). (I) Metaplot for normalized Klf4 (top) and Oct4 (bottom) ChIP-seq signal (RPKM) averaged across all ESC super enhancers for our four reprogramming stages. Oct4 data for MEFs were not available since it is not expressed in these cells. 
